A Pilot Study of FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs F-18 fluorothymidine (Primary)
- Indications Solid tumours
- Focus Diagnostic use
- 08 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2018.
- 08 May 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2018.
- 08 May 2017 Status changed from suspended to recruiting.